TerrAscend (TSNDF) Exchange Rate Effect (2021 - 2026)
TerrAscend's (TSNDF) quarterly Exchange Rate Effect came in at $231000.0 in Q1 2026, up 1750.0% year-on-year from $12486.5 in Q1 2025, and up 247.13% on a QoQ basis from -$157000.0 in Q4 2025.
TerrAscend (TSNDF) Exchange Rate Effect (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Exchange Rate Effect data on file, last reported at $231000.0 in Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 1750.0% year-over-year to $231000.0 in Q1 2026; TTM through Mar 2026 was -$327000.0, a 174.15% decrease from a year earlier, with the FY2025 full-year figure at -$572000.0, down 187.6% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $231000.0, up from -$157000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for TSNDF reached as high as $951000.0 in Q4 2022 and fell as low as -$3.4 million in Q1 2022.
- Historically, Exchange Rate Effect has averaged -$161882.4 across 5 years, with a median of -$14000.0 in 2025.
- Across the five-year window, Exchange Rate Effect tumbled 192.19% in 2025 and surged 1750.0% in 2026, its largest moves.
- Year by year, Exchange Rate Effect stood at $951000.0 in 2022, then tumbled by 115.14% to -$144000.0 in 2023, then jumped by 360.42% to $375000.0 in 2024, then sank by 141.87% to -$157000.0 in 2025, then jumped by 247.13% to $231000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $231000.0 in Q1 2026, -$157000.0 in Q4 2025, and -$224000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 231,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231,000.00 |
| Mar 31, 2026 | 231,000.00 |
| Dec 31, 2025 | -157,000.00 |
| Dec 31, 2025 | -157,000.00 |
| Sep 30, 2025 | -224,000.00 |
| Sep 30, 2025 | -224,000.00 |
| Jun 30, 2025 | -177,000.00 |
| Jun 30, 2025 | -177,000.00 |
| Mar 31, 2025 | -14,000.00 |
| Mar 31, 2025 | -14,000.00 |
| Dec 31, 2024 | 375,000.00 |
| Dec 31, 2024 | 375,000.00 |
| Sep 30, 2024 | -112,000.00 |
| Sep 30, 2024 | -112,000.00 |
| Jun 30, 2024 | 192,000.00 |
| Jun 30, 2024 | 192,000.00 |
| Mar 31, 2024 | 198,000.00 |
| Mar 31, 2024 | 198,000.00 |
| Dec 31, 2023 | -144,000.00 |
| Dec 31, 2023 | -144,000.00 |